Vgi Partners Pty Ltd buys $49,953,431 stake in Mead Johnson Nutrition CO (MJN)

Mead Johnson Nutrition CO (MJN) : Vgi Partners Pty Ltd scooped up 13,088 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 561,590 shares of Mead Johnson Nutrition CO which is valued at $49,953,431.Mead Johnson Nutrition CO makes up approximately 14.03% of Vgi Partners Pty Ltd’s portfolio.

Other Hedge Funds, Including , Ft Options sold out all of its stake in MJN during the most recent quarter. The investment firm sold 1,100 shares of MJN which is valued $97,845.Thrivent Financial For Lutherans boosted its stake in MJN in the latest quarter, The investment management firm added 270 additional shares and now holds a total of 5,778 shares of Mead Johnson Nutrition CO which is valued at $513,953.California Public Employees Retirement System boosted its stake in MJN in the latest quarter, The investment management firm added 19,300 additional shares and now holds a total of 488,200 shares of Mead Johnson Nutrition CO which is valued at $43,103,178. Mead Johnson Nutrition CO makes up approx 0.07% of California Public Employees Retirement System’s portfolio.Royal London Asset Management Ltd reduced its stake in MJN by selling 7,586 shares or 10.76% in the most recent quarter. The Hedge Fund company now holds 62,909 shares of MJN which is valued at $5,554,236. Mead Johnson Nutrition CO makes up approx 0.09% of Royal London Asset Management Ltd’s portfolio.

Mead Johnson Nutrition CO closed down -1.75 points or -2.06% at $83.32 with 17,73,221 shares getting traded on Thursday. Post opening the session at $84.6, the shares hit an intraday low of $82.73 and an intraday high of $84.71 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Mead Johnson Nutrition CO reported $0.88 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.78. The company had revenue of $941.50 million for the quarter, compared to analysts expectations of $963.64 million. The company’s revenue was down -8.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.76 EPS.

Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. CLSA Upgraded Mead Johnson Nutrition CO on Aug 3, 2016 to ” Outperform”, Price Target of the shares are set at $96.Mead Johnson Nutrition CO was Downgraded by Societe Generale to ” Hold” on Jul 29, 2016. Mead Johnson Nutrition CO was Upgraded by JP Morgan to ” Overweight” on Jul 26, 2016.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Leave a Reply

Mead Johnson Nutrition CO - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mead Johnson Nutrition CO. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.